Snowball logo
logo
3002

Hunan Er Kang Pharmaceutical

300267 SHE
¥3.34+¥0.05  (1.52%)
Estimate
EPS
-0.19
Beta
0.424
Growth
Revenue, YoY
-30.03%
Net income, YoY
-53.37%
FCF, YoY
-32.35%
About the company
Ticker
300267
ISIN
CNE100001781
Country
China
Sector (GICS)
Healthcare
Hunan Er-Kang Pharmaceutical Co., Ltd engages in the research and development, production, and sale of pharmaceutical excipients, APIs and finished drugs in China and internationally. The company offers various APIs, such as glycerin, dilute hydrochloric acid, dihydroxypropyl theophylline, sulbenicillin sodium, dihydroxypropyl theophylline, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. It also provides finished drugs, including sulbenicillin sodium for injection and compound liquorice tablets. In addition, the company offers conventional pharmaceutical excipients, such as pharmaceutical glycerin, medicinal ethanol, medicinal propylene glycol, medicinal sodium hydroxide, and sucrose; and new pharmaceutical excipients comprising of hydroxypropyl starch empty capsules, hydroxypropyl starch soft capsules, and citrate products. Hunan Er-Kang Pharmaceutical Co., Ltd was founded in 2003 and is based in Changsha, China.

Frequently asked questions

What sector does Hunan Er Kang Pharmaceutical (300267) operate in?

Hunan Er Kang Pharmaceutical belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Hunan Er Kang Pharmaceutical (300267) current stock price?

As of the latest data, Hunan Er Kang Pharmaceutical stock price is CN¥3.34, with a previous close of CN¥3.29. Hunan Er Kang Pharmaceutical gained CN¥0.05 in the last trading session, representing a 1.52% increase.

What is Hunan Er Kang Pharmaceutical (300267) current market capitalization?

Hunan Er Kang Pharmaceutical market cap is approximately 6.89 billion.

What is Hunan Er Kang Pharmaceutical (300267) Earnings Per Share (EPS)?

The trailing EPS is -CN¥0.19.

Does Hunan Er Kang Pharmaceutical (300267) pay dividends?

No. Hunan Er Kang Pharmaceutical does not pay a dividend.

What is Hunan Er Kang Pharmaceutical (300267) beta (volatility) score?

Hunan Er Kang Pharmaceutical has a beta of 0.424, indicating lower volatility than the overall market.